PLEASANTON, Calif., July 12,
2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq:
TXG), a leader in single cell and spatial biology, today announced
that it will report financial results for the second quarter ended
June 30, 2024 after market close on
Thursday, August 8, 2024. The company
will host a public conference call and live webcast for analysts
and investors beginning at 1:30 p.m. Pacific
Time / 4:30 p.m. Eastern Time
to discuss its results, business developments and outlook. The news
release with the financial results will be accessible from the
company's website prior to the conference call.
Live audio of the webcast will be available on the "Investors"
section of the company website at: www.10xgenomics.com. The
webcast will be archived and available for replay for at least 45
days after the event.
About 10x Genomics
10x Genomics is a life science technology company building
products to accelerate the mastery of biology and advance human
health. Our integrated solutions include instruments, consumables
and software for single cell and spatial biology, which help
academic and translational researchers and biopharmaceutical
companies understand biological systems at a resolution and scale
that matches the complexity of biology. Our products are behind
breakthroughs in oncology, immunology, neuroscience and more,
fueling powerful discoveries that are transforming the world's
understanding of health and disease. To learn more, visit
10xgenomics.com or connect with us on LinkedIn
or X (Twitter).
Disclosure Information
10x Genomics uses filings with the Securities and Exchange
Commission, our website (www.10xgenomics.com), press releases,
public conference calls, public webcasts and our social media
accounts as means of disclosing material non-public information and
for complying with our disclosure obligations under Regulation
FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-second-quarter-2024-financial-results-on-august-8-2024-302195451.html
SOURCE 10x Genomics, Inc.